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Summary
The MID1 gene in Xp22 codes for a novel member of
proteins containing a RING finger, B-box, coiled-coil
and a conserved C-terminal domain. Initially, three mu-
tations in the C-terminal region were found in patients
with Opitz G/BBB syndrome, a defect of midline de-
velopment. Here we have determined the complete gene
structure of the MID1 gene and have analyzed all nine
exons for mutations in a set of 40 unrelated Opitz G/
BBB patients. We now report six additional mutations
all clustered in the carboxy-terminal domain of the
MID1 protein. These data suggest that this conserved
domain of the B-box proteins may play a fundamental
role in the pathogenesis of Opitz syndrome and in mor-
phogenetic events at the midline during blastogenesis.
Introduction
The Opitz G/BBB syndrome (OS) is a multisystem dis-
order comprising primarily hypertelorism and hypospa-
dias, but also additional anomalies—such as clefts of lip
and palate, heart defects, imperforate anus, develop-
mental delay, and tracheo-laryngeal and esophageal ab-
normalities, especially in males (Christian et al. 1969;
Opitz et al. 1969a, 1969b; Opitz 1987). In the initial
clinical reports, the G and BBB syndromes were thought
to represent distinct entities until a family was described
that segregated both sets of anomalies (Cordeiro and
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Holmes 1978). It was appreciated at an early stage of
syndrome delineation that the major organ systems af-
fected in Opitz G/BBB syndrome involve midline struc-
tures; however, the molecular basis of Opitz syndrome
was determined only recently (Quaderi et al. 1997).
Males with OS are frequently more severely affected
than their sisters, whose only finding may be hyperte-
lorism. The generally milder findings in affected females
and the pedigrees of the initially reported families are
consistent with X-linked inheritance. In contrast, addi-
tional reports of male-to-male transmission in OS were
compatible only with autosomal dominant inheritance
(Stoll et al. 1978; Farndon and Donnai 1983). Robin et
al. (1995) resolved this discrepancy with evidence for
genetic linkage to markers either to Xp22 or 22q11.2.
This was the first instance of a classic multiple–
congenital-anomalies syndrome shown to be genetically
heterogeneous, with an X-linked and an autosomal
form. Interestingly, the clinical spectrum of anomalies
appeared to be virtually identical between the two modes
of inheritance (Robin et al. 1996).
Further support for an Opitz gene on Xp22 came from
detailed linkage studies (May et al. 1997) and molecular
analysis of a key pericentric inversion of the X chro-
mosome, inv(X)(p22.3q36) in a French OS family (Ver-
loes et al. 1995). When genes in the vicinity of the
Xp22.3 breakpoint were examined, a single gene, MID1
(midline 1), was identified as the OS gene, on the basis
of its location with respect to the inversion breakpoint
and mutations in three of the X-linked families (Quaderi
et al. 1997). Interestingly, in all three families the mu-
tation was in the C-terminal region of the MID1 protein;
however, these studies did not analyze the entire MID1
gene.
In order to confirm that mutations of the MID1 gene
cause the X-linked form of OS and to extend the spec-
trum of disease-causing mutations, we set out to examine
a large cohort of OS patients. Here we report the entire
gene structure of MID1 and mutational analysis of all
nine exons of the coding region in 40 unrelated patients.
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Table 1
Sequences of PCR Primers Used to Amplify All MID1 Exons in OS Patients and Controls
EXON DOMAIN
PRIMER
(5′–3′)
PRODUCT
(bp)
Tm
(C)Forward Reverse
1 RING finger 3876, GACCTCCCTGTGCCTAATC 3856, GGCTGAGGGTGATGACATG 296 50
1 B box 1 3857, CATGTCATCACCCTCAGCC 3797, ATGTGAGAGTCCGGAATTGG 328 58
1 B box 2 3859, CCAATTCCGGACTCTCACA 3877, GTAGCTAGCAGTGAATACAC 251 56
2 Coiled-coil 3968, TATCTGAAGTATAAAAGTATGC 3969, CAAAACCTTGATCTGGCAGT 225 54
3 Coiled-coil 3994, GCCAAATTAACACTTACCATTG 3995, AGTCCCTGGAGTGTATTAGG 217 54
4 Coiled-coil 3974, AGACCACCCATGTAACCATC 3906, AATCACAGGGCAGATACAAG 251 54
5 3871, GCAGTGATGTTGAAAGTCATC 3889, AAGCAATACCTGTAAGGTAATG 197 52
6 3979, TCTGAAATGGTATCCCAGTTG 3978, ATCAATCTGAAGAAAGCCACC 261 54
7 3835, CTTGTGCCAAAGAACTGCAC 3870, GAGCAGATAAGACATGACAG 246 56
8 C-terminal 3869, TTGAAAATATGCTATTGGTTATG 3825, AGTACAGAATGAGATGTGCC 245 55
9 C-terminal 3868, ATGTGCAACATGGCTCATTG 3769, GACACTTGTTCCACACGGTG 334 56
9 3830, CACCGTGTGGAACAAGTGTC 3892, GTAATCCTGATTATGTTTCTC 348 57
Patients and Methods
Patients
Twenty-two families with OS, as well as 18 individuals
with sporadic OS (and, when available, their parents),
participated in this study. Three of these OS families with
mutations in the MID1 gene have been described else-
where (Quaderi et al. 1997). Here we have identified
MID1 mutations in five additional OS families (8/22
[36%]) and in one apparently sporadic OS patient (1/
18 [6%]). Detailed clinical findings, including photo-
graphs, were reported for kindred OS3 (Brooks et al.
1992). All of the OS patients either were personally eval-
uated or had photographs and clinical records reviewed
by one of the authors (J.M.O. or M.M.). Kindred OS14
consisted of two affected brothers, their affected mother,
and an affected maternal aunt. The index case had hy-
pertelorism with widow’s peak, hypospadias and uni-
lateral cryptorchidism, and an imperforate anus. Only
the propositus, his mother, and his unaffected father
were available for molecular analysis. In kindred OS19
two brothers were affected, one with hypertelorism, se-
vere hypospadias, and imperforate anus and the other
with hypertelorism, unilateral cleft lip and palate, and
hypospadias. Their sister and mother both had hyper-
telorism. DNA samples from all four of these individuals
and from the unaffected father were available for mo-
lecular studies. Kindred OS28 consisted of a large family
with numerous affected individuals. The propositus had
hypertelorism, cleft palate, esophageal-tracheal fistula,
and ambiguous genitalia. For the molecular analysis,
samples from two females with hypertelorism were avail-
able. In kindred OS36, the index case had hypertelorism
with broad nasal bridge and widow’s peak, a unilateral
cleft lip, an esophageal cleft with dysphagia, a ventric-
ular-septal defect, umbilical hernia, and hypospadias.
His mother had mild hypertelorism and a widow’s peak.
One apparently sporadic OS patient had hypertelorism
and hypospadias. He was considered to be a sporadic
case, since his parents, who were not available for mo-
lecular analysis, appeared to be clinically normal. In-
formed consent was obtained from all individuals, ac-
cording to the standards set by local review boards.
DNA Analysis
Genomic DNA from affected and unaffected members
of OS families, apparently sporadic OS individuals, and
their parents was extracted from lymphocytes or estab-
lished lymphoblastoid cell lines by routine methods.
DNA samples were amplified by PCR using 12 different
MID1-specific primer pairs (table 1). Each PCR reaction
(final volume 15 ml) contained 60 ng DNA; 200 mM
each of dATP, dGTP, and dTTP; 62.5 mM dCTP; 5 mCi
a[32P]-dCTP (800 Ci/mmol [10 mCi/ml]); 25 pmol each
primer; 1% formamide; 10 mM Tris-HCl pH 8.3; 50
mM KCl; 1.5 mM MgCl2; 0.0001% (w/v) gelatin; and
1 U AmpliTaq polymerase (Perkin-Elmer). Reactions
were performed in a Hybaid Omnigene Temperature Cy-
cler, with the annealing temperatures (Tm) specified in
table 1. The program consisted of an initial denaturing
step (95C for 5 min) followed by 35 PCR cycles (95C
for 45 s, Tm for 1 min, and 72C for 30 s) and a terminal
extension step (72C for 10 min).
For SSCP analysis, the a[32P]-dCTP–labeled PCR
products were electrophoresed under two different con-
ditions in a 0.5% MDE gel (AT Biochem) with or with-
out 5% glycerol, at room temperature. Amplicons dem-
onstrating SSCP bandshifts were analyzed by the Nucleic
Acid/Protein Core Facility of the Children’s Hospital of
Philadelphia by use of an ABI 377A automated se-
quencer. DNA samples showing SSCP alterations were
compared with those of other members from the same
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family to assess allele segregation and with 1100 X chro-
mosomes from unrelated unaffected control individuals.
Results
The MID1 gene was localized to a mega-YAC in Xp22
that spans the short arm breakpoint of the inversion,
inv(X)(p22.3q36), which segregated with OS in a 20-
member multigenerational French family (Verloes et al.
1995; Quaderi et al. 1997). Complete sequencing of the
intron-exon boundaries by use of cosmid templates dem-
onstrated that the MID1 coding region consists of nine
exons distributed over a 300-kb interval. The genomic
structure of the MID1 gene is represented in figure 1A.
The intron-exon boundaries are detailed in table 2.
For mutational study using SSCP analysis, we selected
18 cases of apparently sporadic and 22 familial OS cases
without evidence of male-to-male transmission that we
considered as compatible with X linkage. The small size
of many of the OS families precluded linkage studies.
The SSCP mutational screen employed 12 pairs of prim-
ers that encompassed all of the intron-exon boundaries
and coding regions of the gene, as shown in table 1.
Our results show the conserved C-terminal domain to
be the most common site involved in structural muta-
tions in OS (fig. 1B). Among this panel of 40 OS patients
a total of 12 sequence variations were detected as band
shifts and were confirmed by direct sequencing of the
amplicons. One of these band shifts is caused by a poly-
morphism in the intron immediately preceding exon 3
(table 2). Two of these band shifts are predicted to be
polymorphisms (C1452T and A1884G), since they do
not alter the amino acid at these positions, whereas the
remaining nine sequence variations predict structural
changes in the MID1 protein, with a clustering of effects
in the C-terminal domain of the protein (fig. 1B). None
of these mutations were detected in 1100 normal X
chromosomes.
Predicted Polymorphisms
The first of the two predicted polymorphisms occurs
at nucleotide C1452T and predicts no change in the
amino acid Thr422 in exon 6. This base-pair change
was identified in a female with OS. All three of her
affected children (two sons and one daughter) do not
carry the C1452T change, suggesting that it is indeed a
polymorphism (Cotton and Scriver 1998). Similarly, the
A1884G sequence variation does not predict an alter-
native codon for Glu566 in exon 9 and, therefore, pre-
dicts no change in the primary structure of the MID1
protein. The A1884G change was identified in a mother
and her son with OS. Both of them had been shown to
carry a 24-bp insertion in exon 8 of the MID1 gene (the
family of these individuals have been designated as
“OS20” by Quaderi et al. [1997]), suggesting that the
sequence variation (A1884G) and the insertion are in
the same MID1 allele. Both of these polymorphisms are
rare, since neither was seen in the normal controls.
A third polymorphism was detected 15 bases 5′ of the
intron/exon boundary of the start of exon 3, as a sub-
stitution of a T for the normal G. This sequence variant
was observed only in the normal control samples and
not in OS individuals and does not occur in the sequence
context of a donor or acceptor splice site. A total of five
normal individuals were detected, by SSCP analysis, as
being either homozygous or heterozygous for this se-
quence variation, as confirmed by DNA sequencing.
Missense Mutations
Two disease-associated missense mutations were ob-
served in the familial group. The first of these occurred
within the coiled-coil domain at nucleotide position
T982C and predicts a substitution of an Arg residue for
the normal Cys at position 266 of the amino acid se-
quence. This sequence change is presumed to cause Opitz
syndrome in OS3, since it can be seen to segregate with
the disease, from an affected mother to her affected son
(fig. 2a). The second missense mutation occurred within
the C-terminal domain at position T1793C and predicts
a substitution of Thr for the normal Ile at amino acid
536. This amino acid position is adjacent to a highly
conserved domain in the C-terminal region; however,
this particular residue itself is not conserved among
members of the B-box family. This sequence change also
segregates with the phenotype of Opitz syndrome in
OS36 (fig. 2d).
Deletions
The deletion of an ATG codon at nucleotide 1498 in
OS5 has been described elsewhere (Quaderi et al. 1997).
A second deletion of a single G base pair at position
1134 in OS14 is predicted to result in a frameshift and
termination of the protein, within three subsequent co-
dons (figs. 1B and 2b). The resulting protein is predicted
to be missing the end of the coiled-coil domain and the
entire C-terminal domain.
Splice-Acceptor Mutation
A single putative splicing mutation was detected in
the 3′ splice-acceptor sequence in OS19 (fig. 2c) and
predicts a substitution of a GG for the invariant AG at
the end of intron 6. This sequence is shown also in table
2, which tabulates the sequences of the intron-exon
boundaries of the MID1 gene. Although reverse tran-
scription–PCR experiments have not yet defined the mo-
lecular consequences for this sequence change (since a
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Figure 1 Spectrum of MID1 mutations in familial and sporadic Opitz G/BBB syndrome (OS). A, Nucleotide and predicted amino acid
sequence of the MID1 cDNA (modified from Quaderi et al. 1997). Conserved Cys and His residues in the RING and B-box domains are circled.
Missense mutations are indicated by the nucleotide changes (upper row in each set of paired rows) above and resulting amino acid changes
(lower row in each set of paired rows), below the wild-type sequence. Polymorphisms are indicated by nucleotide changes (in boldface) above
the wild-type sequence: C1452T (Thr422) and A1884G (Glu566). Missense mutations are indicated in an identical fashion: T982C leads to a
Cys266Arg change (in OS3; see fig. 2a), and T1793C predicts a Ile536Thr change (in OS36; see fig. 2d). The splice-site mutation and the intron
2 sequence variant are described in table 2. Deletions are indicated by an inverted “V” (^) above the sequence: a 1-bp deletion, 1134delG,
leads to a frameshift and premature stop codon at position 1156 (in OS14; see fig. 2b), and an in-frame 3-bp deletion, 1498DATG, predicting
a single amino acid deletion, DM438, in OS5, which has been described elsewhere (Quaderi et al. 1997). A single nucleotide insertion is indicated
by a “” above the sequence: 1745insG, in OS16 (Quaderi et al. 1997). The initial positions of the tandemly duplicated sequences are identified
by an asterisk: *1  1669ins160 (in OS28), *2  1713ins13 (in sporadic case OS; see fig. 2e), and *3  1787ins24 (in OS20 [Quaderi et al.
1997]). B, Diagrammatic representation of nucleotide sequence of the various altered MID1 genes in OS, with respect to the functional domains:
the RING finger (Freemont et al. 1991), the B-box (Reddy et al. 1991), the coiled-coil (Reddy et al. 1992), and the C-terminal domain (Quaderi
et al. 1997). The positions of codon variants are indicated by the arrows. Blackened triangles denote the position of the microdeletions, the
positions of the direct repeats are indicated by the horizontal arrows, and the sizes of the repeats are given below the unblackened triangles.
second blood sample was not available), it is tempting
to speculate that this mutation results in either an un-
stable transcript or a significant alteration in the protein
structure encoded by exons 7–9, because of use of an
alternative upstream or downstream splice-acceptor site.
Head-to-Tail Direct Repeats in the C-Terminal Domain
as the Cause of Frameshift Truncations
No fewer than four direct repeats of the C-terminal
coding region were observed in familial OS, with the
first two (1745insG, in OS16; and 1787ins24, in OS20)
having been described elsewhere (Quaderi et al. 1997).
The 1745insG results in a frameshift with premature
termination within 16 codons, whereas the 1787ins24
causes an in-frame addition of eight amino acids,
FIDSGRHL. Here we report two additional frameshift
mutations resulting from direct repeats in the coding
sequence. The first of these occurred in OS28 and re-
sulted from the tandem duplication of 160 bp at position
1669. It is not until six codons into the second repeat
that a termination codon is encountered, suggesting that
the protein is intact for the first 528 amino acids and
then terminates prematurely in the C-terminal domain.
As shown in figure 2e, one of the apparently sporadic
OS patients (whose parents were unavailable) has a di-
rect repeat, of 13 bp at position 1713, that predicts
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Table 2
MID1 Splice Junctions
EXON
SPLICE SITEa
EXON SIZE
(bp)3′ 5′
1 tcttgtttccag/ATAGCTGATCAG GACAAATTGAAG/gttagtccgatc 716
2 ttttttgaacag/CAAAACTTAGAG CAACATGTTGAA/gtgagtatctct 96
3 cttatcctgtag/GTCAATGCATCA AAAGAAGGGAAG/gtatgatttcta 108
4 cttttgattaag/GTGATGAGGCTT TATCACCGAGAG/gtgagtgcaggg 149
5 tttgcattacag/AGTCTCCATGGC ATTACCTTACAG/gtattgtctttt 128
6 tgagccccacag/CTCCCAACCCTC CCAACGTCGTTA/gtgagtatctca 144
7 ttggctttgcag/GTCTGTGTAATT TGAAGACAAACA/gtaagtgctgtg 162
8 atttgttttcag/GCCAACCATTTA TGGAAGCACATG/gtaagcaactta 209
9 ttgtttccgcag/GTATGCCATTGG ) )
a Exon sequences are represented by uppercase letters, and intron sequences are represented
by lowercase letters. The only substantial difference between our results and those of Perry et
al. (1998) involve the beginning of exon 1, which is attributed to alternative splicing of the 5′
UTR; only minor sequence differences within a few of the introns are observed. In OS19, a
putative 3′ splice acceptor–site mutation (underlined in the sequence that follows) was identified:
ttggctttgcgg/GTCTGTGTAATT (see fig. 2c). An A at position 2 is invariant in all higher
eukaryotes. At position 15 upstream of exon 3, a sequence variant—a T substituted for the
normal G (underlined in the sequence that follows) within the intron 2 sequence, ccatt(g/
t)tacttatcctgtag/GTCAATGCATCA—was observed in five normal control individuals.
termination of the protein as soon as the translational
machinery encounters the TGA at the beginning of the
second repeat.
Discussion
Elsewhere, we have described the identification of the
MID1 gene (Quaderi et al. 1997), the latest member of
a family of proteins with a characteristic RING-finger
motif that consists of a cluster of conserved Cys/His
residues that ligate to zinc atoms in a novel tetrahedral
“cross-brace,” clearly distinct from classical zinc-finger
motifs (Borden and Freemont 1996). A gene identical to
MID1 has been identified independently by another
group and has been named “FXY” (Perry et al. 1998).
The two gene structures are identical with respect to the
coding region and differ only in the alternative splicing
of the 5′ UTR (table 2).
This RING-finger family includes 180 members of di-
verse cellular function, including putative transcriptional
activators, developmental genes, protooncogenes, and
viral replication genes (Freemont et al. 1991; Freemont
1993; Saurin et al. 1996). A subset of this large gene
family contains a second zinc-binding motif called the
“B box” (Reddy and Etkin 1991; Borden et al. 1996).
The B-box motif consists of a second zinc-coordinated
protein fold with a configuration of Cys/His clusters dis-
tinct from the RING domain and from typical zinc fin-
gers. Some members of the B-box family have one or
two zinc-binding domains. Most members of the B-box
family, including MID1, contain a third conserved do-
main, which is rich in hydrophobic amino acids, in a
tandem series of a-helices that form the coiled-coil do-
main (Reddy et al. 1992). The function of the coiled-
coil domain is thought to include an important protein-
protein interaction surface. Proteins with the complete
tripartite structure include MID1 (Quaderi et al. 1997),
PML, rfp, T18, and rpt-1, which regulates the interleu-
kin-2 receptor a-chain (Patarca et al. 1988). Additional
examples include the lupus autoantigen Ro/SS-A (Chan
et al. 1991), efp (an estrogen responsive gene) (Inoue et
al. 1993), xnf7 (Xenopus nuclear factor 7) (Reddy et al.
1991; Borden et al. 1993), and a nuclear proteinPwA33,
which binds to amphibian lampbrush chromosomal
loops (Bellini et al. 1993). Many, but not all, of these
gene products are nuclear in intracellular location and
are found in very large macromolecular assemblages,
x600 kD (Borden and Freemont 1996). Presumably, the
protein-interaction domains inherent in the tripartite
structure influence these protein aggregations. At pre-
sent, the composition of these macromolecular com-
plexes is unknown.
Mutations in MID1 account for 8/22 (36%) of the
OS familial cases. The fact that only 1/18 (6%) of the
apparently sporadic cases could be attributed to a MID1
mutation could be due to phenocopies, locus heteroge-
neity (e.g., the autosomal dominant locus for OS on
chromosome 22q11.2) or the insensitivity of our screen-
ing method (SSCP analysis). Direct DNA sequencing of
these patients has not yet been performed.
None of the mutations in the MID1 gene associated
with OS in this study alter the structure of either the
RING or B-box domains. A missense mutation T982C
was detected in the coiled-coil domain and could po-
tentially affect the function of this domain. The 1134DG
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Figure 2 Representative chromatograms of MID1 DNA-sequence mutations from individuals with familial and sporadic Opitz G/BBB
syndrome. The pedigree structure of four X-linked OS families is shown, with unaffected (unblackened symbols) and affected individuals
(blackened symbols). DNA-sequence chromatograms of the affected index case, the affected mother, and a female control homozygous for the
wild-type sequence (wt) are shown below each pedigree (a–d). Mothers are heterozygous for the wild-type and mutated alleles. a, T982C,
leading to Cys266Arg. b, 1134delG. Note the presence of double peaks in the mother, 3′ of the deletion, due to the single-base phase shift of
the sequences of the normal and mutant alleles. c, A(2)G splice-site mutation. In the pedigree diagram, the propositus is indicated by an
arrow. d, T1793C, leading to Ile536Thr. e, Patient with sporadic OS, with 1713ins13 tandem duplication (indicated by horizontal square
brackets). The parents of this individual were unavailable for study.
mutation is predicted to truncate the protein within the
coiled-coil domain and would therefore also be missing
the entire C-terminal domain. Similarly, the splice ac-
ceptor mutation A(-2)G in intron 6 would be expected
to alter the structure of the C-terminal domain through
alternative splicing. It is this C-terminal domain that is
the most common region affected by mutations in our
OS families. This novel domain has a high degree of
homology among all of the members of the RING/B-
box family. The present study supports the critical role
of this C-terminal region in the pathogenesis of the OS
malformations. The function of this domain is presently
unknown.
Interestingly, all of the mutations found to date in OS
patients spare the N-terminal region of the protein,
which contains the zinc-finger and B-box domains. This
suggests that a complete loss of function of the MID1
protein may be lethal, or may result in a phenotype
different from OS. However, if this were true, we should
hypothesize that the X-chromosome inversion disrupting
the 5′ UTR of MID1 in OS patients does not abolish
MID1 function completely. The analysis of MID1 pro-
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moter(s) and alternative splicing of the 5′ UTR, as well
as the creation of transgenic mice by homologous re-
combination–carrying MID1 mutations, will address
these issues.
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